Cargando…
N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases
RNA methylation modification is a rapidly developing field in epigenetics. N6-methyladensine (m(6)A) is the most common internal modification in eukaryotic mRNA. m(6)A group regulates RNA splicing, stability, translocation, and translation. Enzymes catalyzing this process were termed as writers, era...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831943/ https://www.ncbi.nlm.nih.gov/pubmed/36644366 http://dx.doi.org/10.1016/j.ekir.2022.10.009 |
_version_ | 1784867955079643136 |
---|---|
author | Luan, Junjun Kopp, Jeffrey B. Zhou, Hua |
author_facet | Luan, Junjun Kopp, Jeffrey B. Zhou, Hua |
author_sort | Luan, Junjun |
collection | PubMed |
description | RNA methylation modification is a rapidly developing field in epigenetics. N6-methyladensine (m(6)A) is the most common internal modification in eukaryotic mRNA. m(6)A group regulates RNA splicing, stability, translocation, and translation. Enzymes catalyzing this process were termed as writers, erasers, and readers. Recent studies have focused on exploring the role of RNA methylation in human diseases. RNA methylation modifications, particularly m(6)A, play important roles in the pathogenesis of kidney diseases. In this review, we provide a brief description of m(6)A and summarize the impact of m(6)A on acute and chronic kidney disease (CKD) and possible future study directions for this research. |
format | Online Article Text |
id | pubmed-9831943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-98319432023-01-12 N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases Luan, Junjun Kopp, Jeffrey B. Zhou, Hua Kidney Int Rep Review RNA methylation modification is a rapidly developing field in epigenetics. N6-methyladensine (m(6)A) is the most common internal modification in eukaryotic mRNA. m(6)A group regulates RNA splicing, stability, translocation, and translation. Enzymes catalyzing this process were termed as writers, erasers, and readers. Recent studies have focused on exploring the role of RNA methylation in human diseases. RNA methylation modifications, particularly m(6)A, play important roles in the pathogenesis of kidney diseases. In this review, we provide a brief description of m(6)A and summarize the impact of m(6)A on acute and chronic kidney disease (CKD) and possible future study directions for this research. Elsevier 2022-10-17 /pmc/articles/PMC9831943/ /pubmed/36644366 http://dx.doi.org/10.1016/j.ekir.2022.10.009 Text en © 2022 Published by Elsevier Inc. on behalf of the International Society of Nephrology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Luan, Junjun Kopp, Jeffrey B. Zhou, Hua N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases |
title | N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases |
title_full | N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases |
title_fullStr | N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases |
title_full_unstemmed | N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases |
title_short | N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases |
title_sort | n6-methyladenine rna methylation epigenetic modification and kidney diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831943/ https://www.ncbi.nlm.nih.gov/pubmed/36644366 http://dx.doi.org/10.1016/j.ekir.2022.10.009 |
work_keys_str_mv | AT luanjunjun n6methyladeninernamethylationepigeneticmodificationandkidneydiseases AT koppjeffreyb n6methyladeninernamethylationepigeneticmodificationandkidneydiseases AT zhouhua n6methyladeninernamethylationepigeneticmodificationandkidneydiseases |